238 related articles for article (PubMed ID: 16192379)
1. Acute gamma-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease.
Comery TA; Martone RL; Aschmies S; Atchison KP; Diamantidis G; Gong X; Zhou H; Kreft AF; Pangalos MN; Sonnenberg-Reines J; Jacobsen JS; Marquis KL
J Neurosci; 2005 Sep; 25(39):8898-902. PubMed ID: 16192379
[TBL] [Abstract][Full Text] [Related]
2. Centrally Delivered BACE1 Inhibitor Activates Microglia, and Reverses Amyloid Pathology and Cognitive Deficit in Aged Tg2576 Mice.
Thakker DR; Sankaranarayanan S; Weatherspoon MR; Harrison J; Pierdomenico M; Heisel JM; Thompson LA; Haskell R; Grace JE; Taylor SJ; Albright CF; Shafer LL
J Neurosci; 2015 Apr; 35(17):6931-6. PubMed ID: 25926467
[TBL] [Abstract][Full Text] [Related]
3. Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology.
Apelt J; Bigl M; Wunderlich P; Schliebs R
Int J Dev Neurosci; 2004 Nov; 22(7):475-84. PubMed ID: 15465277
[TBL] [Abstract][Full Text] [Related]
4. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
[TBL] [Abstract][Full Text] [Related]
5. Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain.
Dovey HF; John V; Anderson JP; Chen LZ; de Saint Andrieu P; Fang LY; Freedman SB; Folmer B; Goldbach E; Holsztynska EJ; Hu KL; Johnson-Wood KL; Kennedy SL; Kholodenko D; Knops JE; Latimer LH; Lee M; Liao Z; Lieberburg IM; Motter RN; Mutter LC; Nietz J; Quinn KP; Sacchi KL; Seubert PA; Shopp GM; Thorsett ED; Tung JS; Wu J; Yang S; Yin CT; Schenk DB; May PC; Altstiel LD; Bender MH; Boggs LN; Britton TC; Clemens JC; Czilli DL; Dieckman-McGinty DK; Droste JJ; Fuson KS; Gitter BD; Hyslop PA; Johnstone EM; Li WY; Little SP; Mabry TE; Miller FD; Audia JE
J Neurochem; 2001 Jan; 76(1):173-81. PubMed ID: 11145990
[TBL] [Abstract][Full Text] [Related]
6. Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease.
Portelius E; Zhang B; Gustavsson MK; Brinkmalm G; Westman-Brinkmalm A; Zetterberg H; Lee VM; Trojanowski JQ; Blennow K
Neurodegener Dis; 2009; 6(5-6):258-62. PubMed ID: 19955704
[TBL] [Abstract][Full Text] [Related]
7. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
Dobarro M; Gerenu G; Ramírez MJ
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694
[TBL] [Abstract][Full Text] [Related]
8. Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice.
Gau JT; Steinhilb ML; Kao TC; D'Amato CJ; Gaut JR; Frey KA; Turner RS
Am J Pathol; 2002 Feb; 160(2):731-8. PubMed ID: 11839594
[TBL] [Abstract][Full Text] [Related]
9. The gamma-secretase inhibitor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester reduces A beta levels in vivo in plasma and cerebrospinal fluid in young (plaque-free) and aged (plaque-bearing) Tg2576 mice.
Lanz TA; Himes CS; Pallante G; Adams L; Yamazaki S; Amore B; Merchant KM
J Pharmacol Exp Ther; 2003 Jun; 305(3):864-71. PubMed ID: 12626636
[TBL] [Abstract][Full Text] [Related]
10. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
[TBL] [Abstract][Full Text] [Related]
11. Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis.
Velliquette RA; O'Connor T; Vassar R
J Neurosci; 2005 Nov; 25(47):10874-83. PubMed ID: 16306400
[TBL] [Abstract][Full Text] [Related]
12. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of extracellular signal-regulated kinase activity improves cognitive function in Tg2576 mice.
Jin P; Choi DY; Hong JT
Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):852-7. PubMed ID: 23013130
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates.
Mitani Y; Akashiba H; Saita K; Yarimizu J; Uchino H; Okabe M; Asai M; Yamasaki S; Nozawa T; Ishikawa N; Shitaka Y; Ni K; Matsuoka N
Neuropharmacology; 2014 Apr; 79():412-9. PubMed ID: 24373902
[TBL] [Abstract][Full Text] [Related]
15. BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease.
Ohno M; Sametsky EA; Younkin LH; Oakley H; Younkin SG; Citron M; Vassar R; Disterhoft JF
Neuron; 2004 Jan; 41(1):27-33. PubMed ID: 14715132
[TBL] [Abstract][Full Text] [Related]
16. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice.
Zohar O; Pick CG; Cavallaro S; Chapman J; Katzav A; Milman A; Alkon DL
Neurobiol Aging; 2005; 26(8):1167-75. PubMed ID: 15917100
[TBL] [Abstract][Full Text] [Related]
18. Presenilin 2 mutation accelerates the onset of impairment in trace eyeblink conditioning in a mouse model of Alzheimer's disease overexpressing human mutant amyloid precursor protein.
Kishimoto Y; Kirino Y
Neurosci Lett; 2013 Mar; 538():15-9. PubMed ID: 23370287
[TBL] [Abstract][Full Text] [Related]
19. Generation of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activity.
Beher D; Wrigley JD; Owens AP; Shearman MS
J Neurochem; 2002 Aug; 82(3):563-75. PubMed ID: 12153480
[TBL] [Abstract][Full Text] [Related]
20. APPepsilon, the epsilon-secretase-derived N-terminal product of the beta-amyloid precursor protein, behaves as a type I protein and undergoes alpha-, beta-, and gamma-secretase cleavages.
Lefranc-Jullien S; Sunyach C; Checler F
J Neurochem; 2006 May; 97(3):807-17. PubMed ID: 16524370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]